ADME DRIVE

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 17 Sept 2024

Owner Info

Superluminal Medicines, Inc.

200 Berkeley Street, 18th Floor

Boston MA 02116, UNITED STATES OF AMERICA

Serial Number

2448949 filed on 5 Apr 2024

Correspondent

Gregory B. Coy Taft Stettinius & Hollister, LLP

One Indiana Square, Suite 3500,

Indianapolis IN 46204,

UNITED STATES OF AMERICA

ADME DRIVE

Classification Information

2448949

5 Apr 2024

5 Apr 2034

WORD

6 Oct 2023

Status Date	Action Taken
17^th Sept 2024	Customer Amendment Made correspondence sent
17^th Sept 2024	Amendment to Address for Service Requested
30^th Jul 2024	International Registration in Australia Protected correspondence sent
29^th Jul 2024	IP Right Registration Published
29^th Jul 2024	Status change to Registered/Protected
21^st May 2024	Application Accepted correspondence sent
20^th May 2024	IP Right has been Examined
20^th May 2024	IP Right Acceptance Published
20^th May 2024	Status change to Accepted
14^th May 2024	Awaiting examination